Loading Events
  • This event has passed.

Improving Lives by Detecting Sexually Transmitted Infections Early

April 13 @ 12:00 pm - 1:00 pm EDT

In the United States, there are more than 100 diagnostic tests and procedures available for detecting diseases and monitoring their progression. Diagnostic tools are also used to guide treatments and evaluate their effectiveness. Some tests are invasive, such as a biopsy or endoscopy; whereas others are noninvasive, such as x-rays and ultrasound imaging procedures.

Innovations in diagnostics provide access to health information, helping women make informed decisions about their health care at every stage of their lives. Screening and diagnostic testing can lead to earlier detection of disease, improve health outcomes, and contribute toward reducing health disparities among women.

SWHR is hosting a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. The events will discuss how to improve health outcomes for diseases and conditions that disproportionately or exclusively affect women, with special a focus on cancers, reproductive health, and bone health.

The SWHR Value of Diagnostics within Women’s Health series includes:

Details

Date:
April 13
Time:
12:00 pm - 1:00 pm EDT
Event Categories:
,

Organizer

SWHR

Goals

  • Discuss the impacts of sexually transmitted infections (e.g., chlamydia, gonorrhea, Mycoplasma genitalium, and trichomoniasis) on women’s health, including disparities in disease burden and access to care
  • Provide an overview of advances in diagnostic tests for patients and key considerations for disease management, including prenatal tests for HIV, Syphilis, and HCV
  • Increase visibility of the patient needs, emphasizing ways to empower women and improve quality of care and sexual health

Panelists

Claire Bristow, PhD, MPH, MSc
Assistant Professor, University of California San Diego
Claire Bristow, PhD, MPH, MSc
Assistant Professor, University of California San Diego

Claire C. Bristow, PhD, MPH, MSc is an epidemiologist focused on prevention, diagnostics and genomics for sexually transmitted infections (STIs) including HIV. She utilizes advanced quantitative and molecular methods to reveal the underlying mechanisms driving the spread of infections. Dr. Bristow is now working to improve technology to detect antimicrobial resistant Neisseria gonorrhoeae and ways to halt the epidemic of resistance. Dr. Bristow received a master’s degree in Global Health and Development from the Institute for Child Health at University College London. She completed her master’s in public health and PhD in epidemiology at University of California Los Angeles. From 2009 – 2012, Dr. Bristow was a senior research associate for the U.S. Centers for Disease Control in the Division of Tuberculosis Elimination and the Global AIDS Program in South Africa. More recently, Dr. Bristow’s research focused on dual elimination of HIV and syphilis and she co-founded dualelimination.org. In this work, Dr. Bristow has conducted comprehensive evaluations of dual rapid tests for the simultaneous detection of HIV infection and syphilis. In addition, Dr. Bristow is committed to improving point-of-care diagnostics for other STIs as well as implementing multiplex molecular diagnostic approaches in global settings. Dr. Bristow co-authored a textbook chapter for the American Society for Microbiology Press Molecular Microbiology: Diagnostic Principles and Practice textbook entitled “Diagnostic Approaches to Genitourinary Tract Infections”. In 2020, Dr. Bristow was presented with the prestigious Young Investigator Award from the American Sexually Transmitted Diseases Association (ASTDA). The ASTDA Young Investigator Award is presented to a person engaged in outstanding work in the field of sexually transmitted diseases.

Fred Wyand
Director of Communications, American Sexual Health Association
Fred Wyand
Director of Communications, American Sexual Health Association

ASHA’s Director of Communications, “Fredo” has been with ASHA since 1997 and has managed the HPV and cervical cancer prevention programs since 2003. He works closely with ASHA’s STI Resource Center programs in addition to the policy office in Washington, DC.

June Gipson, PhD, EdS
President & CEO, My Brother’s Keeper, Inc.
June Gipson, PhD, EdS
President & CEO, My Brother’s Keeper, Inc.

Dr. June Gipson currently serves as the President/CEO of My Brother’s Keeper, Inc. in Ridgeland, MS. She holds a Bachelor degree in Criminal Justice from the University of Southern Mississippi, a Master degree in Education Administration from William Carey College, a Specialist degree in Education Leadership, and a Doctorate of Philosophy in Urban Higher Education from Jackson State University. Dr. Gipson has worked in the public health arena for over 20 years. During her tenure, she has worked diligently as an educator and health professional to implement an array of community-oriented programs that focus on improving the health and wellness of minority communities. Dr. Gipson has expanded her service range into the clinical arena with the establishment of Mississippi’s first LGBTI primary healthcare clinic, Open Arms Healthcare Center. This vibrant, patient-focused healthcare center provides innovative, Preventive, Clinical, and Mental Healthcare services to underserved, underinsured, and underrepresented populations in Mississippi.

Sponsor

SWHR’s Value of Diagnostics within Women’s Health series is supported by an educational sponsorship from Roche. SWHR maintains editorial control and independence over educational content.